|
BIIB's Operating Income Growth by Quarter and Year
Biogen Inc 's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| BIIB Operating Income (in millions $) |
FY 2022 |
FY 2021 |
FY 2020 |
FY 2019 |
| IV Quarter |
December |
-
|
587.10
|
-330.70
|
1,777.70
|
| III Quarter |
September |
-
|
794.00
|
1,086.40
|
1,806.30
|
| II Quarter |
June |
-
|
485.70
|
1,974.50
|
1,955.90
|
| I Quarter |
March |
610.70
|
973.90
|
1,819.90
|
1,502.70
|
| FY |
|
610.70
|
2,840.70
|
4,550.10
|
7,042.60
|
| BIIB Operating Income first quarter 2022 Y/Y Growth Comment |
Biogen Inc reported fall in Operating Income in the first quarter 2022 by -37.29% to $ 610.70 millions, from the same quarter in 2021.
The drop in the first quarter 2022 Biogen Inc 's Operating Income compares unfavorably to the Company's average Operating Income growth of 5.46%.
Looking into first quarter 2022 results within Biotechnology & Pharmaceuticals industry 19 other companies have achieved higher Operating Income growth. While Biogen Inc ' s Operating Income drop of -37.29% ranks overall at the positon no. 1841 in the first quarter 2022.
Explain Operating Income growth
|
| BIIB Operating Income ( Y/Y Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
- |
- |
23.19 % |
| III Quarter |
September |
- |
-26.91 % |
-39.85 % |
6.4 % |
| II Quarter |
June |
- |
-75.4 % |
0.95 % |
61.22 % |
| I Quarter |
March |
-37.29 % |
-46.49 % |
21.11 % |
-2.09 % |
| FY |
|
- |
-37.57 % |
-35.39 % |
19.6 % |
BIIB Operating Income (Quarter on Quarter Growth %) |
2022
|
2021 |
2020 |
2019 |
| IV Quarter |
December |
- |
-26.06 % |
- |
-1.58 % |
| III Quarter |
September |
- |
63.48 % |
-44.98 % |
-7.65 % |
| II Quarter |
June |
- |
-50.13 % |
8.49 % |
30.16 % |
| I Quarter |
March |
4.02 % |
- |
2.37 % |
4.13 % |
| FY (Year on Year) |
|
- |
-37.57 % |
-35.39 % |
19.6 % |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 106.48 % |
5.46 % |
-50.43 % |
| (Sep. 30, 2006) |
|
(June 30. 2006) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 106.48 % |
5.46 % |
-50.43 % |
| (Sep. 30, 2006) |
|
(June 30. 2006) |
|
| Operating Income by Quarter for the Fiscal Years 2019, 2020, 2021, 2022 |
Biogen Inc 's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 340.82 % |
10.67 % |
-54.29 % |
| (Dec. 31, 2005) |
|
(Sep. 30, 2005) |
| BIIB's I. Quarter Q/Q Operating Income Comment |
Biogen Inc achieved in the I. Quarter 2022 below company average Operating Income growth of 4.02% quarter on quarter, to $ 610.70 millions.
Even if the I. Quarter 2022 Biogen Inc 's Operating Income quarter on quarter growth was below the regular , this was yet good news, as the current expension, eclipses the % surge in the same quarter a year ago
Within Biotechnology & Pharmaceuticals industry 8 other companies have achieved higher Operating Income quarter on quarter growth. While Biogen Inc 's Operating Income growth quarter on quarter, overall rank is 817. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 340.82 % |
10.67 % |
-54.29 % |
| (Dec. 31, 2005) |
|
(Sep. 30, 2005) |
| BIIB's I. Quarter Q/Q Operating Income Comment |
Biogen Inc achieved in the I. Quarter 2022 below company average Operating Income growth of 4.02% quarter on quarter, to $ 610.70 millions.
I. Quarter 2022 Biogen Inc 's performance were paradoxical, albeit beneath the regular, yet it demonstrates a quite acceleration measured to the % in the I. Quarter a year ago Mathilde Lambert, market researcher wrote.
Within Biotechnology & Pharmaceuticals industry 8 other companies have achieved higher Operating Income quarter on quarter growth. While Biogen Inc 's Operating Income growth quarter on quarter, overall rank is 817. |
|
Biogen Inc 's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Mar 31 2022) |
12 Months Ending
(Dec 31 2021) |
12 Months Ending
(Sep 30 2021) |
12 Months Ending
(Jun 30 2021) |
12 Months Ending
(Mar 31 2021) |
| Cumulative Operating Income 12 Months Ending |
$ 2,477.50 |
$ 2,840.70 |
$ 1,922.90 |
$ 2,215.30 |
$ 3,704.10 |
| Y / Y Operating Income Growth (TTM) |
-33.11 % |
-37.57 % |
-71.12 % |
-69.98 % |
-49.67 % |
| Year on Year Operating Income Growth Overall
Ranking |
# 1670 |
# 231 |
# 103 |
# 140 |
# 1865 |
| Seqeuential Operating Income Change (TTM) |
-12.79 % |
47.73 % |
-13.2 % |
-40.19 % |
-18.59 % |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 1841 |
# 22 |
# 110 |
# 2097 |
# 107 |
| Cumulative Operating Income growth
Comment |
Biogen Inc showed decline, but improvement compare to trailing twelve month Operating Income decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Biogen Inc 's annual Operating Income fall would be -33.11% year on year to $2,478 millions.
In the Healthcare sector 119 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 231 to 1670. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
106.48 % |
5.46 % |
-50.43 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
443.68 % |
31.02 % |
-71.12 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 20 |
| Sector |
# 140 |
| S&P 500 |
# 1841 |
|
| Cumulative Operating Income growth
Comment |
Biogen Inc showed decline, but improvement compare to trailing twelve month Operating Income decrease in Dec 31 2021. If the fiscal year would end in Mar 31 2022, Biogen Inc 's annual Operating Income drop would be -33.11% year on year to $2,478 millions.
In the Healthcare sector 119 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 231 to 1670. |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
106.48 % |
5.46 % |
-50.43 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
443.68 % |
31.02 % |
-71.12 % |
|
|
|
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 20 |
| Sector |
# 140 |
| S&P 500 |
# 1841 |
|
